Reza Mehrazin

10PUBLICATIONS
82CO-AUTHORS
Other creative arts and writing not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 09, 2026
Reply by Authors.

|Apr 19, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.

|Mar 17, 2026
Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky

|Feb 26, 2026
A Tumor-Promoting Inflammatory SPP1+ Macrophage-IL6-CRP Axis Drives Immune Dysfunction in Bladder Cancer.

Michelle A Tran, Byuri Angela Cho, Sudeh Izadmehr

|Jul 07, 2025
Diagnostic Accuracy of [18F]-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy: Is Pelvic Lymph Node Dissection Still Necessary?

Ahmed Eraky, Neeraja Tillu, Reuben Ben-David

|Apr 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group).

Ahmed Eraky, Reuben Ben-David, Gabriele Bignante

Pageof 2

Frequent Collaborators

7 joint publications

John P Sfakianos

6 joint publications

Reuben Ben-David

5 joint publications

Peter Wiklund

4 joint publications

Ahmed Eraky